Clay B. Siegall, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Clay B. Siegall, Ph.D.
Clay B. Siegall, Ph.D. is recorded as CEO at Immunome Inc. (IMNM). Immunome Inc. reported in an 8-K filed October 4, 2023 that Clay B. Siegall, Ph.D. was appointed Chairman and CEO.
“Clay B. Siegall, Ph.D., former co-founder & CEO of Seagen, Inc., appointed as Chairman and CEO”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-10-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunome Inc.
Other people whose current roles at this company are on record from its filings.
- Clay Siegall CEO
- Corleen Roche CFO
- Diane Marcou CFO
- Max Rosett CFO
- Matthew K. Robinson CTO
- Sandra Stoneman General Counsel
- Bob Lapetina Chief Accounting Officer
- Carol Schafer Board Member
- Franklyn G. Prendergast, M.D., Ph.D. Board Member
- Franklyn Prendergast Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.